CYB5D2 and hepatocellular carcinoma: CYB5D2 overexpression can partially counteract the inhibition of HCC cell proliferation, migration, and invasion as well as the regulation of EMT markers by TGF-β, suggesting a complex interaction between CYB5D2 and TGF-β in regulating HCC progression.